ACSS2
Acetyl-coenzyme A synthetase, cytoplasmic
Also known as: ACAS2, AceCS, ACS, ACSA, ACSA_HUMAN, dJ1161H23.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NR19
- Gene
- ACSS2
- Ensembl
- ENSG00000131069
- Chromosome
- 20
- Canonical length
- 701 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a cytosolic enzyme that catalyzes the activation of acetate for use in lipid synthesis and energy generation. The protein acts as a monomer and produces acetyl-CoA from acetate in a reaction that requires ATP. Expression of this gene is regulated by sterol regulatory element-binding proteins, transcription factors that activate genes required for the synthesis of cholesterol and unsaturated fatty acids. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Canonical amino-acid sequenceUniProt
701 residues, UniProt reviewed canonical sequence.
>Q9NR19|ACSS2
1 MGLPEERVRS GSGSRGQEEA GAGGRARSWS PPPEVSRSAH VPSLQRYREL HRRSVEEPRE
61 FWGDIAKEFY WKTPCPGPFL RYNFDVTKGK IFIEWMKGAT TNICYNVLDR NVHEKKLGDK
121 VAFYWEGNEP GETTQITYHQ LLVQVCQFSN VLRKQGIQKG DRVAIYMPMI PELVVAMLAC
181 ARIGALHSIV FAGFSSESLC ERILDSSCSL LITTDAFYRG EKLVNLKELA DEALQKCQEK
241 GFPVRCCIVV KHLGRAELGM GDSTSQSPPI KRSCPDVQIS WNQGIDLWWH ELMQEAGDEC
301 EPEWCDAEDP LFILYTSGST GKPKGVVHTV GGYMLYVATT FKYVFDFHAE DVFWCTADIG
361 WITGHSYVTY GPLANGATSV LFEGIPTYPD VNRLWSIVDK YKVTKFYTAP TAIRLLMKFG
421 DEPVTKHSRA SLQVLGTVGE PINPEAWLWY HRVVGAQRCP IVDTFWQTET GGHMLTPLPG
481 ATPMKPGSAT FPFFGVAPAI LNESGEELEG EAEGYLVFKQ PWPGIMRTVY GNHERFETTY
541 FKKFPGYYVT GDGCQRDQDG YYWITGRIDD MLNVSGHLLS TAEVESALVE HEAVAEAAVV
601 GHPHPVKGEC LYCFVTLCDG HTFSPKLTEE LKKQIREKIG PIATPDYIQN APGLPKTRSG
661 KIMRRVLRKI AQNDHDLGDM STVADPSVIS HLFSHRCLTI QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACSS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 110 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 110 nTPM
- tongue: 93 nTPM
- adipose tissue: 65 nTPM
- duodenum: 61 nTPM
- colon: 51 nTPM
- heart muscle: 47 nTPM
Single-cell type
- cardiomyocytes: 522 nCPM
- adipocytes: 426 nCPM
- myonuclei: 359 nCPM
- breast lactating cells: 357 nCPM
- goblet cells: 263 nCPM
- colonocytes: 244 nCPM
Immune cell
- basophil: 35 nTPM
- myeloid DC: 23 nTPM
- classical monocyte: 22 nTPM
- intermediate monocyte: 13 nTPM
- neutrophil: 12 nTPM
- total PBMC: 9.2 nTPM
Brain region
- white matter: 45 nTPM
- pons: 39 nTPM
- cerebral cortex: 33 nTPM
- medulla oblongata: 32 nTPM
- basal ganglia: 32 nTPM
- thalamus: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.08
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acetate biosynthetic process
- acetyl-CoA biosynthetic process
- acetyl-CoA biosynthetic process from acetate
- ethanol catabolic process
- lipid biosynthetic process
- long-term memory
- propionate biosynthetic process
Molecular functions
- acetate-CoA ligase activity
- AMP binding
- ATP binding
- chromatin binding
- propionate-CoA ligase activity
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AMP-dependent synthetase/ligase domain
- Acetate-CoA ligase
- AMP-binding, conserved site
- AMP-binding enzyme, C-terminal domain
- Acetyl-coenzyme A synthetase, N-terminal domain
- ANL, N-terminal domain
- AMP-binding enzyme domain superfamily
- AMP-binding enzyme
- AMP-binding enzyme C-terminal domain
- Acetyl-coenzyme A synthetase N-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACSS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACSS2 as an antibody target. Whether an autoantibody or antibody against ACSS2 could matter depends on whether native ACSS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACSS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACSS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...